PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
1-Year Return
49.19%
This Quarter Return
-19.3%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$82.8M
AUM Growth
-$28.8M
(-26%)
Cap. Flow
-$3.77M
Cap. Flow
% of AUM
-4.55%
Top 10 Holdings %
Top 10 Hldgs %
36.35%
Holding
122
New
10
Increased
23
Reduced
52
Closed
15
Top Buys
| 1 |
CareDx
CDNA
|
$906K |
| 2 |
Gilead Sciences
GILD
|
$792K |
| 3 |
BEAT
BioTelemetry, Inc.
BEAT
|
$589K |
| 4 |
Rockwell Medical
RMTI
|
$456K |
| 5 |
VG
Vonage Holdings Corporation
VG
|
$436K |
Top Sells
| 1 |
Aflac
AFL
|
$1.02M |
| 2 |
Microvision
MVIS
|
$808K |
| 3 |
The Joint Corp
JYNT
|
$802K |
| 4 |
CEMI
Chembio diagnostics, Inc.
CEMI
|
$780K |
| 5 |
ANI Pharmaceuticals
ANIP
|
$709K |
Sector Composition
| 1 | Healthcare | 65.82% |
| 2 | Technology | 10.84% |
| 3 | Communication Services | 7.03% |
| 4 | Industrials | 5.89% |
| 5 | Consumer Staples | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AbbVie
ABBV
$371B
| $1.09M | 1.32% |
14,338
-200
| -1% | -$15.2K |
|
|
AKTS
27
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $1.07M | 1.29% |
199,150
-4,350
| -2% | -$23.4K |
|
28
Castle Biosciences
CSTL
$698M
| $1.01M | 1.22% |
33,850
+6,455
| +24% | +$192K |
|
29
Digital Turbine
APPS
$473M
| $1.01M | 1.22% |
233,550
-19,250
| -8% | -$83K |
|
30
Merck
MRK
$210B
| $986K | 1.19% |
13,430
+995
| +8% | +$73.1K |
|
31
Inuvo
INUV
$51.4M
| $950K | 1.15% |
401,872
+133,929
| +50% | +$317K |
|
32
Bristol-Myers Squibb
BMY
$95.1B
| $941K | 1.14% |
16,875
-300
| -2% | -$16.7K |
|
33
Target
TGT
$41.6B
| $909K | 1.1% |
9,779
-2,050
| -17% | -$191K |
|
34
Tactile Systems Technology
TCMD
$300M
| $854K | 1.03% |
21,267
-83
| -0.4% | -$3.33K |
|
35
Verizon
VZ
$183B
| $828K | 1% |
15,409
| – | – |
|
|
PFIE
36
DELISTED
Profire Energy, Inc
PFIE
| $827K | 1% |
1,049,489
+434,689
| +71% | +$343K |
|
37
LifeVantage
LFVN
$144M
| $822K | 0.99% |
79,810
| – | – |
|
38
3M
MMM
$82B
| $799K | 0.97% |
7,004
+2,691
| +62% | +$307K |
|
|
39
Gilead Sciences
GILD
$144B
| $792K | 0.96% |
+10,600
| New | +$792K |
|
|
HTGM
40
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $791K | 0.96% |
13,522
-517
| -4% | -$30.2K |
|
41
Ciena
CIEN
$16.8B
| $766K | 0.93% |
19,250
-1,000
| -5% | -$39.8K |
|
42
Advanced Micro Devices
AMD
$246B
| $730K | 0.88% |
16,050
-3,000
| -16% | -$136K |
|
43
CVS Health
CVS
$89.1B
| $698K | 0.84% |
11,769
-2,066
| -15% | -$123K |
|
|
QUMU
44
DELISTED
Qumu Corp.
QUMU
| $677K | 0.82% |
408,000
-19,000
| -4% | -$31.5K |
|
45
Standard BioTools
LAB
$520M
| $646K | 0.78% |
254,267
+30,684
| +14% | +$78K |
|
46
Alphatec Holdings
ATEC
$2.42B
| $644K | 0.78% |
186,750
+100,750
| +117% | +$347K |
|
47
Ooma
OOMA
$355M
| $631K | 0.76% |
52,850
-1,000
| -2% | -$11.9K |
|
48
BioLife Solutions
BLFS
$1.26B
| $610K | 0.74% |
64,250
-17,300
| -21% | -$164K |
|
49
Sensus Healthcare
SRTS
$53.1M
| $590K | 0.71% |
235,944
-1,242
| -0.5% | -$3.11K |
|
|
ATRS
50
DELISTED
Antares Pharma, Inc.
ATRS
| $548K | 0.66% |
232,166
-24,667
| -10% | -$58.2K |
|